[Hormone replacement therapy and osteoporosis].
Estrogen therapy has clearly been shown to maintain bone mass and to reduce postmenopausal bone loss, thereby lowering the risk of osteoporotic fractures. Current estrogen use is better than past use for maintenance of bone density and current estrogen therapy begun 10 or more years after the menopause might be as beneficial as continuous treatment begun at the time of menopause.